Enoxacin has been previously reported to inhibit the growth of cancer cells by enhancing miRNA processing through a direct physical interaction with TARBP2 miRNA (Shan et al. 2008; Melo et al. 2011; Cornaz-Buros et al. 2014). The gene discussed is TARBP2; the disease is cancer.